Detection of SYT-SSX1/2 fusion transcripts by reverse transcriptase- polymerase chain reaction (RT-PCR) is a valuable diagnostic tool in synovial sarcoma

European Journal of Cancer

Volumn 34, Issue 13, 1998, Pages 2087-2093

  Willeke, F ^b   Mechtersheimer, G ^b   Schwarzbach, M ^b   Weitz, J ^b   Zimmer, D ^b   Lehnert, T ^a   Herfarth, Ch ^b   Von Knebel Doeberitz, M ^b   Ridder, R ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

Minimal residual disease; RT PCR; Sarcoma; SYT SSX1 2; Translocation

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME TRANSLOCATION X; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPINDLE CELL; SYNOVIAL SARCOMA;

ADOLESCENT; ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SARCOMA, SYNOVIAL; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 0032403571     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00240-8     Document Type: Article

References (35)

1. 1. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994, 372, 143-149.
2. 2. Becher R, Wake N, Gibas Z, Ochi H, Sandberg AA. Chromosome changes in soft tissue sarcomas. J Natl Cancer Inst 1984, 72, 823-831.
3. 3. Limon J, Dal Cin P, Sandberg AA. Translocations involving the X chromosome in solid tumors: presentation of two sarcomas with t(X;18)(q13;p11). Cancer Genet Cytogenet 1986, 23, 87-91.
4. 4. Turc-Carel C, Dal Cin P, Limon J, et al. Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci USA 1987, 84, 1981-1985.
5. 5. Reeves BR, Smith S, Fisher C, et al. Characterization of the translocation between chromosomes X and 18 in human synovial sarcomas. Oncogene 1989, 4, 373-378.
6. 6. Clark J, Rocques PJ, Crew AJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994, 7, 502-508.
7. 7. Crew AJ, Clark J, Fisher C, et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 1995, 14, 2333-2340.
8. 8. Leeuw B de, Balemans M, Olde Weghuis D, Geurts van Kessel A. Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas. Hum Mol Genet 1995, 4, 1097-1099.
9. 9. Fligman I, Lonardo F, Jhanwar SC, Gerald WL, Woodruff J, Ladanyi M. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am J Pathol 1995, 47, 1592-1599.
10. 10. Bruijn DRH de, Baats E, Zechner U, et al. Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcomas. Oncogene 1996, 13, 643-648.
11. 11. Türeci Ö, Sahin U, Schobert I, et al. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 1996, 56, 4766-4772.
12. 12. Santos NR dos, Bruijn DRH de, Balemans M, et al. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion protein. Hum Mol Genet 1997, 6, 1549-1558.
13. 13. Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localized in nuclear bodies. Hum Mol Genet 1997, 6, 1559-1564.
14. 14. Weiss SW. WHO: Histological typing of soft tissue tumors. Berlin, Springer, 1994.
15. 15. Enzinger FM, Weiss SW. Soft tissue tumours. St Louis, Mosby Year Book, 1995.
16. 16. Presant CA, Russell WO, Alexander RW, Fu YS. Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol 1986, 4, 1658-1661.
17. 17. Dickersin GR. Synovial sarcoma: a review and update, with emphasis on the ultrastructural characterization of the non-glandular component. Ultrastruct Pathol 1991, 15, 379-402.
18. 18. Hermanek P, Sobin LH. UICC: TNM-classification of malignant tumors. Berlin, Springer, 1992.
19. 19. Weitz J, Kienle P. Lacroix J, et al. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res 1998, 4, 343-348.
20. 20. Shipley J, Crew J. Birdsall S, et al. Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. Am J Pathol 1996, 148, 559-567.
21. 21. Dockhorn-Dworniczak B, Schäfer KL, Blasius S, et al. Assessment of molecular genetic detection of chromosome translocations in the differential diagnosis of pediatric sarcomas. Klin Padiatr 1997, 209, 156-164.
22. 22. Knight JC, Reeves BR, Smith S, et al. Cytogenetic and molecular analysis of synovial sarcoma. Int J Oncol, 1992, 1, 747-752.
23. 23. Poteat HT, Corson JM, Fletcher JA. Detection of chromosome 18 rearrangement in synovial sarcoma by fluorescence in situ hybridization. Cancer Genet Cytogenet 1995, 84, 76-81.
24. 24. Busam KJ, Fletcher CDM. The clinical role of molecular genetics in soft tissue tumor pathology. Cancer Met Rev 1997, 16, 207-227.
25. 25. Dei Tos AP, Dal Cin P. The role of cytogenetics in the classification of soft tissue tumours. Virchows Arch 1997, 431, 83-94.
26. 26. Barr FG, Chatten J, D'Cruz CM, et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 1995, 273, 553-557.
27. 27. Nagao K, Ito H, Yoshida H. Chromosomal translocation t(X;18) in human synovial sarcomas analyzed by fluorescence in situ hybridization using paraffin-embedded tissue. Am J Pathol 1996, 148, 601-609.
28. 28. Sozzi G, Minoletti F, Miozzo M, et al. Relevance of cytogenetic and fluorescent in situ hybridization analyses in the clinical assessment of soft tissue sarcoma. Hum Pathol 1997, 28, 134-142.
29. 29. Harris M, Hartley AL. Value of peer review of pathology in soft tissue sarcomas. In Verweij J, Pinedo HM, Suit HD, eds. Soft tissue sarcomas: present achievements and future prospects. Boston, Kluwer Academic, 1997, 1-8.
30. 30. Noguchi S-I, Ueki T, Kawauchi S, et al. Establishment and characterization of a new synovial sarcoma cell line, SN-SY-1: special reference to bcl-2 protein and SYT-SSX1 hybrid transcript. Int J Cancer 1997, 72, 995-1002.
31. 31. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998, 338, 153-160.
32. 32. Drexler HG, Borkhardt A, Janssen JW. Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction. Leuk Lymphoma 1997, 19, 359-380.
33. 33. Israeli RS, Miller Jr WH, Su SL, et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assay. Cancer Res 1994, 54, 6306-6310.
34. 34. Willeke F, Ridder R, Mechtersheimer G, et al. Analysis of FUSCHOP fusion transcripts in different types of soft tissue sarcoma and their diagnostic implication. Clin Cancer Res (in press).
35. 35. De Graaf H, Maelandsmo GM, Ruud P, et al. Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2. Int J Cancer 1997, 72, 191-196.